Pritzker School of Medicine, University of Chicago, Chicago, Illinois.
Section of Urology, Department of Surgery, University of Chicago, Chicago, Illinois.
J Urol. 2017 Mar;197(3 Pt 1):684-689. doi: 10.1016/j.juro.2016.09.073. Epub 2016 Sep 20.
Testicular cancer is the most common malignancy among young men and well established treatment guidelines exist to optimize outcomes. We characterized errors in the management of testicular cancer observed among patients seen at 3 referral centers in the United States.
We retrospectively reviewed data from 593 patients presenting with testicular cancer to 3 academic medical centers from 2007 to 2016. Nonguideline directed care was defined as management differing from National Comprehensive Care Network guideline recommendations. Cases of nonguideline directed care were systematically described. Patient and tumor characteristics were compared between guideline directed care and nonguideline directed care. Multivariable logistic regression was used to identify predictors of nonguideline directed care, and Cox regression modeling was used to assess the association between nonguideline directed care and relapse-free survival.
Nonguideline directed care was identified in 177 of 593 (30%) patients. Inappropriate imaging (44%) and overtreatment (40%) were the most common classifications. Misdiagnosis (24%) and under treatment (16%) occurred relatively frequently, while inappropriate treatment (6%) was rare. Multivariable Cox regression modeling controlling for race, tumor stage and tumor histology identified nonguideline directed care as a significant predictor of relapse (HR 2.49, 95% CI 1.61-3.85, p <0.01).
Nonguideline directed care of patients with testicular cancer is common, most frequently in the form of inappropriate imaging and overtreatment. Nonguideline directed care leads to delayed definitive therapy, unnecessary morbidity and higher rates of relapse.
睾丸癌是年轻人中最常见的恶性肿瘤,已经制定了完善的治疗指南来优化治疗效果。本研究旨在描述美国 3 家转诊中心就诊的睾丸癌患者在治疗中存在的错误。
我们回顾性分析了 2007 年至 2016 年间,3 所学术医疗中心就诊的 593 例睾丸癌患者的临床资料。非指南指导的治疗是指与国家综合癌症网络指南推荐的治疗方案不同的治疗。系统地描述了非指南指导治疗的病例。比较了指南指导治疗和非指南指导治疗的患者和肿瘤特征。采用多变量逻辑回归分析来确定非指南指导治疗的预测因素,并采用 Cox 回归模型评估非指南指导治疗与无复发生存率之间的关系。
593 例患者中,有 177 例(30%)存在非指南指导治疗。最常见的分类是非适当的影像学检查(44%)和过度治疗(40%)。误诊(24%)和治疗不足(16%)相对常见,而不适当的治疗(6%)则较为罕见。多变量 Cox 回归模型控制了种族、肿瘤分期和肿瘤组织学,发现非指南指导治疗是复发的显著预测因素(HR 2.49,95%CI 1.61-3.85,p <0.01)。
睾丸癌患者的非指南指导治疗较为常见,最常见的是不适当的影像学检查和过度治疗。非指南指导治疗会导致确定性治疗延迟、不必要的发病率增加和复发率升高。